Myriad’s Human-Gene Patent Rehearing Ordered by High Court – Businessweek

March 26, 2012 Posted By: Leave a comment
The Myriad case pits the biotechnology industry ... the information they convey are patentable is of paramount importance to the future of patent law, the advancement of medical science and patients’ health,” the challengers to the Myriad ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>